This startup develops cardiac CT scanning technology for early heart disease detection. Their Coronary CTA services provide detailed 3D images of the heart and blood vessels, enabling assessment of plaque buildup, blockages, and other arterial abnormalities.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional methods of diagnosing coronary artery disease (CAD) may detect the condition late, potentially missing opportunities for early intervention and prevention. Lack of accessible and affordable cardiac imaging can delay diagnosis, leading to increased healthcare costs and compromised patient outcomes. Current testing methods may also be invasive, causing patient discomfort and increasing procedural risks.
Solution
Clear Heart & Lung Imaging offers non-invasive cardiac CT scanning services designed for early and accurate detection of heart disease. Their outpatient imaging center utilizes advanced CT technology to visualize coronary arteries and identify plaque buildup, arterial abnormalities, and other indicators of CAD. By providing detailed 3D images, Clear Heart & Lung enables physicians to diagnose CAD up to a decade earlier than traditional methods, facilitating timely treatment and preventive strategies. The service aims to minimize radiation exposure while offering a cost-effective alternative to more invasive procedures.
Target Audience
The primary target audience includes asymptomatic individuals seeking proactive heart health assessments, patients with suspected CAD, and referring physicians looking for advanced diagnostic imaging solutions.
Features
- Coronary CTA (Computed Tomography Angiography) for detailed visualization of coronary arteries.
- Plaque and FFR (Fractional Flow Reserve) analysis to identify high-risk plaque and assess blood flow.
- Calcium scoring to detect the presence and extent of calcification in the coronary arteries.
- Lung screening for early detection of lung disease.
- Minimal radiation exposure due to fast rotation speed and focused field of view.